Why Is CNA Financial (CNA) Up 2% Since Last Earnings Report?
https://www.zacks.com/stock/news/2284143/why-is-cna-financial-cna-up-2-since-last-earnings-report?cid=CS-ZC-FT-realtime_blog-2284143
Jun 05, 2024 - CNA Financial (CNA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
SentinelOne (S) and Advantage Team Up for Purple AI Integration
https://www.zacks.com/stock/news/2284231/sentinelone-s-and-advantage-team-up-for-purple-ai-integration?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2284231
Jun 05, 2024 - SentinelOne (S) partners with Advantage to transform MDR services with PurpleAI integration, offering AI-driven defense against cyber threats.
0
Ollie's Bargain (OLLI) Q1 Earnings Beat Estimates, Guidance Up
https://www.zacks.com/stock/news/2284091/ollie-s-bargain-olli-q1-earnings-beat-estimates-guidance-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2284091
Jun 05, 2024 - Ollie's Bargain's (OLLI) first-quarter fiscal 2024 results reflect a comparable store sales increase of 3%.
0
Annexon (ANNX) Up as Phase III Neuro Disorder Study Meets Goals
https://www.zacks.com/stock/news/2284172/annexon-annx-up-as-phase-iii-neuro-disorder-study-meets-goals?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2284172
Jun 05, 2024 - Annexon (ANNX) jumps 31% after meeting the primary and key secondary endpoints with the low dose of its lead candidate, ANX005, in the phase III study for Guillain-Barre syndrome.
0
Want $1,000 in Dividend Income? Here's How Much You Have to Invest in UPS Stock to Get It
https://www.fool.com/investing/2024/06/05/want-1k-dividend-income-how-much-ups-stock/?source=iedfolrf0000001
Jun 05, 2024 - The package delivery giant isn't firing on all cylinders right now, but its stock does offer a compelling dividend.
0
Up 43% to 133%, Is It Too Late to Buy These 3 Stocks?
https://www.fool.com/investing/2024/06/05/up-43-to-133-is-it-too-late-to-buy-these-3-stocks/?source=iedfolrf0000001
Jun 05, 2024 - These stocks are red-hot; is there still time to invest?
0
Humana Is Set Up For Long-Term Success
https://seekingalpha.com/article/4697459-humana-is-set-up-for-long-term-success?source=feed_all_articles
Jun 04, 2024 - Humana's Medicare Advantage expected to benefit from demographic tailwinds. Read why HUM stock's upside potential outweighs the downside.
0
Casa Bonita could open up reservations this summer; documentary about its revival debuts this week
https://www.denverpost.com/2024/06/04/casa-bonita-mi-amor-documentary-matt-stone-trey-parker-reservations/
Jun 04, 2024 - Casa Bonita will be the subject of a new film, and this one isn’t a cartoon. Plus, reservations may be opening to the general public.
0
Workday (WDAY), Google Team Up to Develop AI Native Application
https://www.zacks.com/stock/news/2283550/workday-wday-google-team-up-to-develop-ai-native-application?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2283550
Jun 04, 2024 - Workday (WDAY) integrates Google Cloud's Vertex AI and Gemini models to support enterprises with customized AI-powered application development for business-specific requirements.
0
Agios (AGIO) Up 21% on Upbeat Data From 2nd Thalassemia Study
https://www.zacks.com/stock/news/2283565/agios-agio-up-21-on-upbeat-data-from-2nd-thalassemia-study?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2283565
Jun 04, 2024 - Data from a late-stage study shows that transfusion-dependent thalassemia patients who received Agios' (AGIO) Pyrukynd demonstrated a statistically significant reduction in transfusion burden.
0